IGC Pharma Sees Positive Memory Function Data in Preclinical Study of Alzheimer's Disease Drug
By Sabela Ojea IGC Pharma said its Alzheimer's disease drug candidate TGR-63 demonstrated enhanced memory function in preclinical studies. The pharmaceutical...